None listed
Conditions
Sponsors
Boreum Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: Indian female subjects Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) Between 18 and 35 years of age. Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar .) Having pores and oily skin type.
Exclusion criteria
Exclusion criteria: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months Having refused to give her/his assent by not signing the consent form Taking part in another study liable to interfere with this study Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) Having a progressive asthma (either under treatment or last fit in the last 2 years) Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) Being epileptic. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) Having cutaneous hypersensitivity. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. Having changed her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit. Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted) Having applied hair oil during the entire duration of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in pore appearance and sebum contentTimepoint: Baseline, Day 14, Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Mohit Lalvani
MASCOT-SPINCONTROL India Pvt. Ltd.
Outcome results
None listed